CDBT Stock Overview
Engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
China Dasheng Biotechnology Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.079 |
| 52 Week High | US$0.085 |
| 52 Week Low | US$0.0003 |
| Beta | 0 |
| 1 Month Change | 12.57% |
| 3 Month Change | 57.60% |
| 1 Year Change | 181.43% |
| 3 Year Change | -34.33% |
| 5 Year Change | 236.75% |
| Change since IPO | -96.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| CDBT | US Chemicals | US Market | |
|---|---|---|---|
| 7D | -1.5% | -1.4% | -2.2% |
| 1Y | 181.4% | -1.0% | 18.3% |
Return vs Industry: CDBT exceeded the US Chemicals industry which returned -1% over the past year.
Return vs Market: CDBT exceeded the US Market which returned 18.3% over the past year.
Price Volatility
| CDBT volatility | |
|---|---|
| CDBT Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 5.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 17.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CDBT's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine CDBT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Gang Chen | n/a |
China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases.
China Dasheng Biotechnology Company Fundamentals Summary
| CDBT fundamental statistics | |
|---|---|
| Market cap | US$3.23m |
| Earnings (TTM) | US$6.41m |
| Revenue (TTM) | US$20.95m |
0.0x
P/E Ratio0.0x
P/S RatioIs CDBT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CDBT income statement (TTM) | |
|---|---|
| Revenue | US$20.95m |
| Cost of Revenue | US$10.93m |
| Gross Profit | US$10.02m |
| Other Expenses | US$3.62m |
| Earnings | US$6.41m |
Last Reported Earnings
Mar 31, 2009
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CDBT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/23 02:24 |
| End of Day Share Price | 2025/02/20 00:00 |
| Earnings | 2009/03/31 |
| Annual Earnings | 2008/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
China Dasheng Biotechnology Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.